[go: up one dir, main page]

WO2000012711A8 - Human membrane channel proteins - Google Patents

Human membrane channel proteins

Info

Publication number
WO2000012711A8
WO2000012711A8 PCT/US1999/020468 US9920468W WO0012711A8 WO 2000012711 A8 WO2000012711 A8 WO 2000012711A8 US 9920468 W US9920468 W US 9920468W WO 0012711 A8 WO0012711 A8 WO 0012711A8
Authority
WO
WIPO (PCT)
Prior art keywords
channel proteins
membrane channel
human membrane
mechp
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/020468
Other languages
French (fr)
Other versions
WO2000012711A3 (en
WO2000012711A2 (en
Inventor
Janice Au-Young
Olga Bandman
Y Tom Tang
Roopa Reddy
Jennifer L Hillman
Henry Yue
Preeti Lal
Neil C Corley
Karl J Guegler
Gina Gorgone
Mariah R Baughn
Yalda Azimzai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/155,226 external-priority patent/US6207225B1/en
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to CA002341148A priority Critical patent/CA2341148A1/en
Priority to JP2000567698A priority patent/JP2003520565A/en
Priority to EP99948140A priority patent/EP1117781A2/en
Priority to AU61376/99A priority patent/AU6137699A/en
Publication of WO2000012711A2 publication Critical patent/WO2000012711A2/en
Publication of WO2000012711A3 publication Critical patent/WO2000012711A3/en
Anticipated expiration legal-status Critical
Publication of WO2000012711A8 publication Critical patent/WO2000012711A8/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides new human membrane channel proteins (MECHP) and polynucleotides which identify and encode MECHP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of MECHP.
PCT/US1999/020468 1998-09-02 1999-09-02 Human membrane channel proteins Ceased WO2000012711A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002341148A CA2341148A1 (en) 1998-09-02 1999-09-02 Human membrane channel proteins
JP2000567698A JP2003520565A (en) 1998-09-02 1999-09-02 Human membrane channel protein
EP99948140A EP1117781A2 (en) 1998-09-02 1999-09-02 Human membrane channel proteins
AU61376/99A AU6137699A (en) 1998-09-02 1999-09-02 Human membrane channel proteins

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US09/155,226 US6207225B1 (en) 1996-03-26 1997-03-25 Solventless two-component strippable lacquer for metal surfaces
US14581598A 1998-09-02 1998-09-02
US09/145,815 1998-09-02
US60/155,226 1998-09-02
US19128398A 1998-11-12 1998-11-12
US09/191,283 1998-11-12
US20882198A 1998-12-09 1998-12-09
US15522598P 1998-12-09 1998-12-09
US09/208,821 1998-12-09
US60/155,225 1998-12-09
US23750699A 1999-01-26 1999-01-26
US15521199P 1999-01-26 1999-01-26
US09/237,506 1999-01-26
US60/155,211 1999-01-26
US24789199A 1999-02-10 1999-02-10
US15526399P 1999-02-10 1999-02-10
US60/155,263 1999-02-10
US09/247,891 1999-02-10

Publications (3)

Publication Number Publication Date
WO2000012711A2 WO2000012711A2 (en) 2000-03-09
WO2000012711A3 WO2000012711A3 (en) 2000-08-17
WO2000012711A8 true WO2000012711A8 (en) 2001-05-10

Family

ID=27578559

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/020468 Ceased WO2000012711A2 (en) 1998-09-02 1999-09-02 Human membrane channel proteins

Country Status (1)

Country Link
WO (1) WO2000012711A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
TR200200631T2 (en) * 1998-10-07 2002-06-21 Warner-Lambert Company Alpha-2 / Delta gene
DE19924199A1 (en) * 1999-05-27 2000-11-30 Boehringer Ingelheim Int Tumor Associated Antigen
CN1315445A (en) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 Polypeptide-human gap bindin 8 and polynucleotide for coding it
CN1315444A (en) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 Polypeptide-human gap bindin 10 and polynucleotide for coding it
CN1320619A (en) * 2000-04-27 2001-11-07 上海博德基因开发有限公司 Polypeptide-human gap junction protein 9 and polynucleotide for coding it
CN1322745A (en) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 New polypeptide human gap junction protein 15 and its encoding polynucleotide
AU2001265384A1 (en) 2000-06-06 2001-12-17 Millennium Pharmaceuticals, Inc. 52906, 33408, and 12189, potassium channel family members and uses thereof
EP1319069B1 (en) * 2000-06-28 2008-05-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2001280878A1 (en) * 2000-07-28 2002-02-13 Lexicon Genetics Incorporated Human ion channel proteins and polynucleotides encoding the same
WO2002022684A2 (en) * 2000-09-15 2002-03-21 Incyte Genomics, Inc. Transporters and ion channels
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US20030022205A1 (en) * 2001-05-09 2003-01-30 Millennium Pharmaceuticals, Inc. 98359, a sodium channel beta 4 subunit, and uses therefor
WO2004070388A1 (en) * 2003-02-04 2004-08-19 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases
US7667013B2 (en) 2004-03-31 2010-02-23 Daiichi Sankyo Company, Limited Gene encoding a guanine nucleotide exchange factor and the gene product thereof
KR101105428B1 (en) * 2009-02-12 2012-01-17 경북대학교 산학협력단 Peptides Specific to Glycocan-3 Proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670488A (en) * 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy

Also Published As

Publication number Publication date
WO2000012711A3 (en) 2000-08-17
WO2000012711A2 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
WO2001012662A3 (en) Membrane associated proteins
WO1999061471A3 (en) Human transmembrane proteins
WO2000015793A3 (en) Human gpcr proteins
WO2000012711A8 (en) Human membrane channel proteins
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO2000034477A3 (en) Neuron-associated proteins
WO1999058692A3 (en) Human apoptosis associated proteins
WO2000029583A3 (en) Immunoglobulin superfamily proteins
WO2000009709A3 (en) Proteases and associated proteins
WO2000026245A3 (en) Human membrane transport proteins
WO2000012703A3 (en) Protein transport-associated molecules
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO2000014251A3 (en) Human transferase proteins
WO2000052151A3 (en) Human secretory proteins
WO1999058558A3 (en) Cell signaling proteins
WO1999061614A3 (en) Human socs proteins
WO2000031263A3 (en) Gtpase associated proteins
WO2000020604A3 (en) Oxidoreductase molecules
WO2000028045A3 (en) Human hydrolase proteins
WO1999057270A3 (en) Human receptor molecules
WO1999041373A3 (en) Human transport-associated molecules
WO2000065054A3 (en) Human membrane-associated proteins
WO2000008155A3 (en) Human receptor-associated proteins
WO2000001821A3 (en) Neurotransmission associated proteins
WO1999049037A3 (en) Protein phosphatase-related molecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US US US US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US US US US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase in:

Ref country code: CA

Ref document number: 2341148

Kind code of ref document: A

Format of ref document f/p: F

Ref document number: 2341148

Country of ref document: CA

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2000 567698

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999948140

Country of ref document: EP

WPC Withdrawal of priority claims after completion of the technical preparations for international publication
AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 10/2000 UNDER (30) REPLACE THE EXISTING TEXT BY "60/155226, 02.09.98, US 09/191283, 12.11.98, US NOT FURNISHED, 12.11.98, US 60/155225, 09.12.98, US 60/155211, 26.01.99, US 60/155263, 10.02.99, US" AND UNDER (63) REPLACE THE EXISTING TEXT BY "US, 60/155226 (CIP) FILED ON 02.09.98 US, 09/191283(CIP) FILED ON 12.11.98 US, NOT FURNISHED (CIP) FILED ON 12.11.98 US, 60/155225 (CIP) FILED ON 09.12.98 US, 60/155211 (CIP) FILED ON 26.01.99 US, 60/155263 (CIP) FILED ON 10.02.99"

WWE Wipo information: entry into national phase

Ref document number: 09786133

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1999948140

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999948140

Country of ref document: EP